Cutaneous complications of molecular targeted therapy used in oncology

The new molecular targeted therapy has been developed over the past decades by using the molecular targeted molecular changes discovered in specific types of cancer. Unfortunately, most of these agents (epidermal growth factor receptors, multi-targeted small molecule tyrosine kinase inhibitors, mono...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Med Life
Egile Nagusiak: Lupu, I, Voiculescu, N, Bacalbasa, N, Cojocaru, I, Vrancian, V, Giurcaneanu, C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Carol Davila University Press 2016
Gaiak:
General Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152604/
https://ncbi.nlm.nih.gov/pubmed/27974909
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak